- “Allergan Receives FDA Approval for OZURDEX™ Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease” (Press release issued by Allergan, BusinessWire)
- “Biotech Set to Dominate Drug Industry Growth” (Seeking Alpha)
- “JNJ says review of Cougar Biotech deal is complete” (Forbes)
- “U.S. approves Novartis auto-inflammatory drug” (Reuters)
- “New biological therapy Ilaris® approved in US to treat children and adults with CAPS, a serious life-long auto-inflammatory disease” (Press release issued by Novartis Pharmaceuticals, WebWire)
- “Teva Pharmaceutical (TEVA) PriceWatch Alert for June 18, 2009” (MarketIntelligenceCenter)
- “Aastrom: FDA lifts clinical hold from heart study” (Reuters)
- “Auxilium says FDA panel won’t meet until September” (The Associated Press, Forbes)
THE LATEST WORD
Top Industry Stories – June 18, 2009
Posted on June 18th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics